The dermal fillers and botulinum toxin market was valued at USD 6.8 billion in 2025 and is forecast to register a 3.2% CAGR between 2025 and 2035. In 2025, hyaluronic acid based dermal fillers hold 58.0% of product demand and wrinkle reduction represents 68.0% of application sales.